Drug · DIN 02242879
PREMPLUS
0.625 MG TO 5.0 MG TABLETS
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since November 6, 2019; first marketed May 9, 2002.
- Drug Identification Number (DIN)
- 02242879
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet; Kit
- Route
- Oral
- Therapeutic class (ATC)
- Medroxyprogesterone and estrogen G03FA12
- Class
- Human
- Record last updated
- August 19, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CONJUGATED ESTROGENS | 0.625 MG | |
| MEDROXYPROGESTERONE ACETATE | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 1, 2010: NOC 11782New Drug Submission (NDS) · Manufacturer name change
- April 3, 2003: NOC 408New Drug Submission (NDS) · Manufacturer name change
- October 16, 2000: NOC 1032New Drug Submission (NDS)
Other DINs named PREMPLUS
- DIN 02242878 · Cancelled Post Market